参考文献 References
[1] Citron F, Segatto I, Musco L, et al. miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC[J]. EMBO Mol Med,2021,13(7):e12872.
[2] 龙丹，张春林. 头颈鳞癌中人乳头瘤病毒的检测及意义[J]. 重庆医科大学学报,2022,47(02):217-221.
[3] Paver E C, Currie A M, Gupta R, et al. Human papilloma virus related squamous cell carcinomas of the head and neck: diagnosis, clinical implications and detection of HPV[J]. Pathology,2020,52(2):179-191.
[4] Sabatini M E, Chiocca S. Human papillomavirus as a driver of head and neck cancers[J]. Br J Cancer,2020,122(3):306-314.
[5] Kajitani N, Schwartz S. The role of RNA-binding proteins in the processing of mRNAs produced by carcinogenic papillomaviruses[J]. Semin Cancer Biol,2022,86(Pt 3):482-496.
[6] 周潜，尹跃平. 口咽部人乳头瘤病毒感染检测方法的研究进展[J]. 实用临床医药杂志,2021,25(16):125-128.
[7] de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis[J]. Lancet Glob Health,2020,8(2):e180-e190.
[8] Prime S S, Cirillo N, Cheong S C, et al. Targeting the genetic landscape of oral potentially malignant disorders has the potential as a preventative strategy in oral cancer[J]. Cancer Lett,2021,518:102-114.
[9] Gillison M L, Akagi K, Xiao W, et al. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers[J]. Genome Res,2019,29(1):1-17.
[10] Ma X, Li Y, Liu R, et al. Development of a sensitive and specific nanoparticle‐assisted PCR assay for detecting HPV‐16 and HPV‐18 DNA[J]. Journal of Medical Virology, 2020, 92(12):3793-3798.
[11] Prigge E S, Arbyn M, von Knebel D M, et al. Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis[J]. Int J Cancer,2017,140(5):1186-1198.
[12] Santos F, Invenção M, Araújo E D, et al. Comparative analysis of different PCR-based strategies for HPV detection and genotyping from cervical samples[J]. J Med Virol,2021, 93(11): 6347-6354.
[13] Giorgi R P, Ronco G, Mancuso P, et al. Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial[J]. Int J Cancer,2022,151(7):1047-1058.
[14] Luo R Z, Chen S L, Li M, et al. HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis[J]. Cancer Cell Int,2021,21(1): 643.
[15] Randén-Brady R, Carpén T, Jouhi L, et al. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer[J]. Human Pathology,2019,90:97-105.
[16] Peterson C, Parikh R N, Ahmad M T, et al. Detection of Human Papillomavirus in Squamous Lesions of the Conjunctiva Using RNA and DNA In-Situ Hybridization[J]. Int J Mol Sci,2022,23(13):1-13.
[17] Keung E S, Souers R J, Bridge J A, et al. Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests[J]. Arch Pathol Lab Med,2020, 144(3):344-349.
[18] Lewis J J, Beadle B, Bishop J A, et al. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists[J]. Arch Pathol Lab Med, 2018,142(5):559-597.
[19] Benzerdjeb N, Tantot J, Blanchet C, et al. Oropharyngeal squamous cell carcinoma: p16/p53 immunohistochemistry as a strong predictor of HPV tumour status[J]. Histopathology, 2021, 79(3):381-390.
[20] Mashiana S S, Navale P, Khandakar B, et al. Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance[J]. Oral Oncol,2021,113: 105109.
[21] Sabu A, Ratna Mouli N V, Tejaswini N, et al. Human papillomavirus detection in oropharyngeal squamous cell carcinoma using p16 immunohistochemistry[J]. International Journal of Applied and Basic Medical Research,2019, 9(4):212.
[22] Kreutz J E, Wang J, Sheen A M, et al. Self-digitization chip for quantitative detection of human papillomavirus gene using digital LAMP[J]. Lab Chip,2019,19(6):1035-1040.
[23] Wang J, Staheli J P, Wu A, et al. Detection of 14 High-Risk Human Papillomaviruses Using Digital LAMP Assays on a Self-Digitization Chip[J]. Analytical Chemistry,2021,93(6): 3266-3272.
[24] Hinić S, Rich A, Anayannis N V, et al. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas[J]. Int J Mol Sci,2022,23(18):1-20.
[25] Venuti A, Paolini F. HPV Detection Methods in Head and Neck Cancer[J]. Head and Neck Pathology,2012,6(S1):63-74.
[26] Tanaka H, Suzuki M, Takemoto N, et al. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary[J]. Int J Cancer,2022, 150(1): 174-186.
[27] Mattox A K, D'Souza G, Khan Z, et al. Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer[J]. Oral Oncol, 2022, 128:105805.
[28] Falcucci S, Paolini F, Mileo A M, et al. ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein[J]. ACS Omega,2021,6(13):8778-8783.
[29] Whitmarsh A, Pring M, Thomas S J, et al. Survival advantage in patients with human papillomavirus‐driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000[J]. Cancer,2021,127(14):2442-2452.
[30] Lang Kuhs K A, Wood C B, Wiggleton J, et al. Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer[J]. Cancer,2020,126(11):2658-2665.
[31] Busch C J, Hoffmann A S, Viarisio D, et al. Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study[J]. EClinical Medicine, 2022,53:101659.